[HTML][HTML] The biology, function, and applications of exosomes in cancer
J Liu, L Ren, S Li, W Li, X Zheng, Y Yang, W Fu… - … Pharmaceutica Sinica B, 2021 - Elsevier
Exosomes are cell-derived nanovesicles with diameters from 30 to 150 nm, released upon
fusion of multivesicular bodies with the cell surface. They can transport nucleic acids …
fusion of multivesicular bodies with the cell surface. They can transport nucleic acids …
Circulating biomarkers in patients with glioblastoma
J Müller Bark, A Kulasinghe, B Chua, BW Day… - British journal of …, 2020 - nature.com
Gliomas are the most common tumours of the central nervous system and the most
aggressive form is glioblastoma (GBM). Despite advances in treatment, patient survival …
aggressive form is glioblastoma (GBM). Despite advances in treatment, patient survival …
Therapeutic and diagnostic potential of exosomes as drug delivery systems in brain cancer
DI Avgoulas, KS Tasioulis, RM Papi, AA Pantazaki - Pharmaceutics, 2023 - mdpi.com
Cancer is designated as one of the principal causes of mortality universally. Among different
types of cancer, brain cancer remains the most challenging one due to its aggressiveness …
types of cancer, brain cancer remains the most challenging one due to its aggressiveness …
The function of astrocyte mediated extracellular vesicles in central nervous system diseases
Astrocyte activation plays an important role during disease-induced inflammatory response
in the brain. Exosomes in the brain could be released from bone marrow (BM)-derived stem …
in the brain. Exosomes in the brain could be released from bone marrow (BM)-derived stem …
Emerging prospects of extracellular vesicles for brain disease theranostics
R Wang, X Wang, Y Zhang, H Zhao, J Cui, J Li… - Journal of Controlled …, 2022 - Elsevier
In the past decade, bio-nanoparticles inspired by nature with advantageous properties have
attracted extensive interest for accurate diagnosis and effective treatment. Extracellular …
attracted extensive interest for accurate diagnosis and effective treatment. Extracellular …
Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4
LJ Mo, M Song, QH Huang, H Guan, XD Liu… - British journal of …, 2018 - nature.com
Background An increasing number of studies have recently reported that microRNAs
packaged in exosomes contribute to multiple biological processes such as cancer …
packaged in exosomes contribute to multiple biological processes such as cancer …
Extracellular vesicles: The key for precision medicine in glioblastoma
Glioblastoma (GBM) represents the most aggressive and lethal disease of the central
nervous system. Diagnosis is delayed following the occurrence of symptoms, and treatment …
nervous system. Diagnosis is delayed following the occurrence of symptoms, and treatment …
Exosomes as novel diagnostic biomarkers and therapeutic tools in gliomas
P Skouras, AN Gargalionis, C Piperi - International Journal of Molecular …, 2023 - mdpi.com
Exosomes constitute small extracellular vesicles that contain lipids, proteins, nucleic acids,
and glycoconjugates from the secreted cells and are capable of transmitting signals …
and glycoconjugates from the secreted cells and are capable of transmitting signals …
The exosome journey: from biogenesis to regulation and function in cancers
Y Li, L Meng, B Li, Y Li, T Shen, B Zhao - Journal of Oncology, 2022 - Wiley Online Library
Exosomes are a type of small endosomal‐derived vesicles ranging from 30 to 150 nm,
which can serve as functional mediators in cell‐to‐cell communication and various …
which can serve as functional mediators in cell‐to‐cell communication and various …
[HTML][HTML] Role of exosomes in the progression, diagnosis, and treatment of gliomas
J Shi, Y Zhang, B Yao, P Sun, Y Hao… - … medical journal of …, 2020 - ncbi.nlm.nih.gov
Gliomas are the most common primary malignant brain tumors associated with a low
survival rate. Even after surgery, radiotherapy, and chemotherapy, gliomas still have a poor …
survival rate. Even after surgery, radiotherapy, and chemotherapy, gliomas still have a poor …